|
|
Volumn 29, Issue 3, 1996, Pages 194-
|
|
Letter to the Editor
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN;
ANTIANDROGEN;
BICALUTAMIDE;
FLUTAMIDE;
GONADORELIN DERIVATIVE;
CANCER SURVIVAL;
LETTER;
METASTASIS;
PRIORITY JOURNAL;
PROSTATE CANCER;
CLINICAL TRIAL;
HUMAN;
MALE;
NOTE;
PROSTATE TUMOR;
ANDROGEN ANTAGONISTS;
CLINICAL TRIALS;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
|
|
EID: 0030236552
PISSN: 02704137
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0045(199609)29:3<194::AID-PROS2990290306>3.0.CO;2-Q Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
